The outbreak of COVID-19 is not set to increase growth in 2020, with value growth of 3% predicted, compared to value growth of 4% recorded in 2019. Unlike other countries within Western Europe, there was not a high level of stockpiling reported for consumer health products in Norway. However, adult acetaminophen was one area which recorded a spike in sales in Q1 and Q2, due to the negative press surrounding ibuprofen, and adverse effects the product could have on those suffering from COVID-19.
The Consumer Health in Norway report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.
Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.
Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
The Consumer Health in Norway report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.
Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.
Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Consumer Health market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Note: Product cover images may vary from those shown
EXECUTIVE SUMMARY
GLOBAL INDUSTRY ENVIRONMENT
DISCLAIMER
DEFINITIONS
SOURCES
2020 IMPACT
2020 IMPACT
2020 IMPACT
2020 IMPACT
2020 IMPACT
2020 IMPACT
2020 IMPACT
2020 IMPACT
2020 IMPACT
2020 IMPACT
2020 IMPACT
2020 IMPACT
2020 IMPACT
2020 IMPACT
- COVID-19 impact on consumer health
- COVID-19 country impact
- Company response
- Retailing shift
- What next for consumer health?
- Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2015-2020
- Table 2 Life Expectancy at Birth 2015-2020
- Table 3 Sales of Consumer Health by Category: Value 2015-2020
- Table 4 Sales of Consumer Health by Category: % Value Growth 2015-2020
- Table 5 NBO Company Shares of Consumer Health: % Value 2016-2020
- Table 6 LBN Brand Shares of Consumer Health: % Value 2017-2020
- Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2015-2020
- Table 8 Distribution of Consumer Health by Format: % Value 2015-2020
- Table 9 Distribution of Consumer Health by Format and Category: % Value 2020
- Table 10 Forecast Sales of Consumer Health by Category: Value 2020-2025
- Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2020-2025
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
- Summary 1 OTC: Switches 2019-2020
GLOBAL INDUSTRY ENVIRONMENT
DISCLAIMER
DEFINITIONS
SOURCES
- Summary 2 Research Sources
2020 IMPACT
- Sales of ibuprofen decline as stories suggest the drug has adverse effects on those suffering from COVID-19, causing high levels of growth for acetaminophen
- Diclofenac switches from OTC to Rx status, further boosting sales of adult acetaminophen in 2020
- Paracet set to record double-digit growth, maintaining Karo Pharma AS leading position
- The forecast period will record a solid performance, as topical analgesics/anaesthetic and ibuprofen drive value growth
- The outbreak of COVID-19, increases the interest in health, boosting sales for topical analgesics/anaesthetic
- Prescription analgesics and a lack of innovation on the landscape are both threats to growth across the forecast period
- Table 12 Sales of Analgesics by Category: Value 2015-2020
- Table 13 Sales of Analgesics by Category: % Value Growth 2015-2020
- Table 14 NBO Company Shares of Analgesics: % Value 2016-2020
- Table 15 LBN Brand Shares of Analgesics: % Value 2017-2020
- Table 16 Forecast Sales of Analgesics by Category: Value 2020-2025
- Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2020-2025
2020 IMPACT
- Cough remedies and nasal sprays drive growth, as demand is driven up by the outbreak of COVID-19
- Rising incidence of allergies leads to positive value growth for antihistamines/allergy remedies (systemic)
- Otrivin from GlaxoSmithKline AS records an increase in sales, as nasal sprays sell-out in some stores, due to the outbreak of COVID-19
- Stable growth across the forecast period, driven by paediatric products as well as cough remedies
- A rise in prescription allergy remedies is set to challenge growth for antihistamines/allergy remedies (systemic) across the forecast period
- Nasal sprays and medicated confectionery benefit from providing instant relief, boosting sales and value growth across the forecast period
- Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2015-2020
- Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2015-2020
- Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2016-2020
- Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2017-2020
- Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2020-2025
- Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2020-2025
2020 IMPACT
- COVID-19 restrictions change consumer eating habits, negatively impacting the growth for digestive remedies
- Proton pump inhibitors continue to drive growth, with sales rising as COVID-19 increases consumers stress levels
- Johnson & Johnson retains its lead, as motion sickness remedies records a double-digit decline
- Stable growth across the forecast period, as consumers eat out, travel and socialise once more
- As the outbreak of COVID-19 piques interest in health and wellness, the growing trend sees consumers focus on natural ways to improve their digestion
- The ageing population drives growth across the forecast period, particularly benefiting antiflatulents and laxatives
- Table 24 Sales of Digestive Remedies by Category: Value 2015-2020
- Table 25 Sales of Digestive Remedies by Category: % Value Growth 2015-2020
- Table 26 NBO Company Shares of Digestive Remedies: % Value 2016-2020
- Table 27 LBN Brand Shares of Digestive Remedies: % Value 2017-2020
- Table 28 Forecast Sales of Digestive Remedies by Category: Value 2020-2025
- Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2020-2025
2020 IMPACT
- Frequent handwashing and use of home disinfectants causes skin issues for some consumers, boosting growth for dermatologicals
- Antiparasitics/lice (head and body) treatments record a value decline as the closure of schools reduces the spread of lice
- Well-known brands retain the trust of consumers, with a lack of private label offerings within dermatologicals
- Following a spike in growth due to COVID-19, lower levels to be recorded in 2021; however, positive growth is driven by antipruritics
- Pollution, climate change and an ageing population will remain key growth drivers across the forecast period
- Growing awareness of the effectiveness of antipruritics boosts demand across the forecast period, as the product drives the highest value growth
- Table 30 Sales of Dermatologicals by Category: Value 2015-2020
- Table 31 Sales of Dermatologicals by Category: % Value Growth 2015-2020
- Table 32 NBO Company Shares of Dermatologicals: % Value 2016-2020
- Table 33 LBN Brand Shares of Dermatologicals: % Value 2017-2020
- Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2017-2020
- Table 35 Forecast Sales of Dermatologicals by Category: Value 2020-2025
- Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2020-2025
2020 IMPACT
- The Norwegian Health Institute remove smokers from the groups at risk of COVID-19; therefore, the virus has little impact on sales of NRT smoking cessation aids
- The smoking population continues to decline as health awareness grows in the country
- Nicorette remains the leading player, as supermarkets continue to gain share
- The COVID-19 virus will increase the interest in health and wellness, supporting steady growth across the forecast period
- The threat of e-cigarettes may increase across the forecast period, as a loosening of regulations is under discussion
- Other NRT will lead growth over the forecast period, as consumers invest in mouth sprays for their quick and convenient benefits
- Table 37 Number of Smokers by Gender 2015-2020
- Table 38 Sales of NRT Smoking Cessation Aids by Category: Value 2015-2020
- Table 39 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2015-2020
- Table 40 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2016-2020
- Table 41 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2017-2020
- Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2020-2025
- Table 43 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2020-2025
2020 IMPACT
- COVID-19 adds to consumers stress, however, sleep aids records the same high growth levels seen in 2019
- Women and younger people are growing audiences for sleep aids, with both groups impacted by higher levels of stress
- Sedix retains its lead as consumers preference passion flower over valerian, while smaller players have the opportunity to breakthrough
- Growth is set to remain positive across the forecast period, with the economic recession following the outbreak of COVID-19, increasing consumers stress
- The ongoing changes in the Rx landscape boosts sales of OTC sleep aids across the forecast period
- Melatonin is increasingly seen as a safe alternative to OTC sleep aids, challenging growth across the forecast period
- Table 44 Sales of Sleep Aids: Value 2015-2020
- Table 45 Sales of Sleep Aids: % Value Growth 2015-2020
- Table 46 NBO Company Shares of Sleep Aids: % Value 2016-2020
- Table 47 LBN Brand Shares of Sleep Aids: % Value 2017-2020
- Table 48 Forecast Sales of Sleep Aids: Value 2020-2025
- Table 49 Forecast Sales of Sleep Aids: % Value Growth 2020-2025
2020 IMPACT
- Increasing use of screen time, heightened during Q1 due to the outbreak of COVID-19, impacts the demand for standard eye care
- Allergy eye care continues to be driven by the population in Norway that suffers from pollen allergies, as the pollen count rises
- Norwegians rely on branded eye care products, as SantenPharma AB extends its lead during 2020
- The ongoing use of digital screens, partnered with a rise in allergies, supports high levels of growth
- The ageing population in Norway support the growth of eye care across the forecast period
- Technological improvements in contact lenses are a challenge to growth in standard eye care
- Table 50 Sales of Eye Care by Category: Value 2015-2020
- Table 51 Sales of Eye Care by Category: % Value Growth 2015-2020
- Table 52 NBO Company Shares of Eye Care: % Value 2016-2020
- Table 53 LBN Brand Shares of Eye Care: % Value 2017-2020
- Table 54 Forecast Sales of Eye Care by Category: Value 2020-2025
- Table 55 Forecast Sales of Eye Care by Category: % Value Growth 2020-2025
2020 IMPACT
- Sales of wound care increase, as the COVID-19 restrictions close gyms and training centres, increasing outdoor physical activity and injuries
- The changing demographics impacts growth in wound care, as the older generation drives sales in 2020
- Orkla Group acquires Norgesplaster AS, as Norgesplaster remains the leading offering in 2020
- As consumers go back to the gym, outdoor activities decline, however growth in wound care remains positive across the forecast period
- The recovery time for international travel may improve sales of wound care, as an increasing amount of consumers holiday outdoors in Norway
- The summer months and the increasing health and wellness trend are opportunities for growth across the forecast period
- Table 56 Sales of Wound Care by Category: Value 2015-2020
- Table 57 Sales of Wound Care by Category: % Value Growth 2015-2020
- Table 58 NBO Company Shares of Wound Care: % Value 2016-2020
- Table 59 LBN Brand Shares of Wound Care: % Value 2017-2020
- Table 60 Forecast Sales of Wound Care by Category: Value 2020-2025
- Table 61 Forecast Sales of Wound Care by Category: % Value Growth 2020-2025
2020 IMPACT
- The outbreak of COVID-19 saw consumers increase their purchases of vitamins in Q1 and Q2, reaching for products they believed would benefit the immune system
- As well as the outbreak of COVID-19, growth in 2020 is supported by the prevalence of vitamin D deficiencies, and the increasing popularity of vitamin K2
- Takeda AS leads the landscape with sales of Nycoplus, while e-commerce sees an increase in growth, due to the outbreak of COVID-19
- Growth will remain steady across the forecast period, with a slight increase compared to growth recorded in 2020
- Driven by the outbreak of COVID-19, immunity-boosting ingredients drive sales across the forecast period
- COVID-19 leads to an increase in e-commerce sales, set to improve the online landscape across the forecast period
- Table 62 Sales of Vitamins by Category: Value 2015-2020
- Table 63 Sales of Vitamins by Category: % Value Growth 2015-2020
- Table 64 Sales of Multivitamins by Positioning: % Value 2015-2020
- Table 65 NBO Company Shares of Vitamins: % Value 2016-2020
- Table 66 LBN Brand Shares of Vitamins: % Value 2017-2020
- Table 67 Forecast Sales of Vitamins by Category: Value 2020-2025
- Table 68 Forecast Sales of Vitamins by Category: % Value Growth 2020-2025
2020 IMPACT
- Lack of footfall in shopping centres stifles growth in 2020, as consumers stick to essential retailers during the peak of the COVID-19 crisis
- Despite an ongoing scepticism surrounding dietary supplements, fish oils/omega fatty acids drive strong value growth and sales
- Orkla extends its lead with Møller’s, while e-commerce continues to grow its share, as COVID-19 leads to reduced sales within specialist stores
- Dietary supplements see a rise in growth across the forecast period, as consumers return to shopping in specialist stores
- Health and fitness trends, boosted by the outbreak of COVID-19, drive sales of mineral supplements across the forecast period
- Sustainability is a growing concern, with manufacturers of fish oils responding accordingly, across the forecast period
- Table 69 Sales of Dietary Supplements by Category: Value 2015-2020
- Table 70 Sales of Dietary Supplements by Category: % Value Growth 2015-2020
- Table 71 Sales of Dietary Supplements by Positioning: % Value 2015-2020
- Table 72 NBO Company Shares of Dietary Supplements: % Value 2016-2020
- Table 73 LBN Brand Shares of Dietary Supplements: % Value 2017-2020
- Table 74 Forecast Sales of Dietary Supplements by Category: Value 2020-2025
- Table 75 Forecast Sales of Dietary Supplements by Category: % Value Growth 2020-2025
2020 IMPACT
- The focus on a healthy, homemade diet during the outbreak of COVID-19, leads to a decline in growth for weight management and wellbeing
- Many Norwegians have a growing scepticism towards weight loss supplements, further impacting the decline seen in 2020
- Nutricia Norway AS increases its lead, while direct sellers continue to have a wide share of the landscape
- Growth increases across the forecast period, as consumers reach for slimming teas and supplement nutrition drinks
- Supplement nutrition drinks drive high value growth across the forecast period, seen as an easy and convenient solution
- Manufacturers promote their products to align with the growing health and wellness trend, aiding sales over the forecast period
- Table 76 Sales of Weight Management and Wellbeing by Category: Value 2015-2020
- Table 77 Sales of Weight Management and Wellbeing by Category: % Value Growth 2015-2020
- Table 78 NBO Company Shares of Weight Management and Wellbeing: % Value 2016-2020
- Table 79 LBN Brand Shares of Weight Management and Wellbeing: % Value 2017-2020
- Table 80 Forecast Sales of Weight Management and Wellbeing by Category: Value 2020-2025
- Table 81 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2020-2025
2020 IMPACT
- Closures of gyms and the reluctancy to visit shopping centres leads to a decline in growth for sports nutrition
- Consumers adapt their workout routines, leading to less demand for sports nutrition
- Proteinfabrikken AS maintains its lead, as e-commerce sees a further boost in share due to the outbreak of COVID-19
- Following a decline due to the COVID-19 lockdown, growth will peak in 2021 as consumers return to their previous workout regimes
- The health and wellness trend sees consumers avoiding sugar, giving manufacturers the opportunity to adapt their offerings
- Manufacturers are set to diversify their offerings to avoid growing maturity seen in some areas of sports nutrition
- Table 82 Sales of Sports Nutrition by Category: Value 2015-2020
- Table 83 Sales of Sports Nutrition by Category: % Value Growth 2015-2020
- Table 84 NBO Company Shares of Sports Nutrition: % Value 2016-2020
- Table 85 LBN Brand Shares of Sports Nutrition: % Value 2017-2020
- Table 86 Forecast Sales of Sports Nutrition by Category: Value 2020-2025
- Table 87 Forecast Sales of Sports Nutrition by Category: % Value Growth 2020-2025
2020 IMPACT
- Lack of footfall in specialist retailers leads to a decline in growth for 2020, as the COVID-19 crisis does not motivate consumers to buy herbal/traditional options
- Sleep aids benefit from having a better reputation than prescribed alternatives, however, herbal/traditional cough and cold remedies lose sales to OTC products
- Läkerol retains the top spot, as Sedix benefits from its passionate fruit ingredient, increasing its lead above its competitors
- Following a decline in 2020, growth peaks in 2021, before remaining steady across the rest of the forecast period
- A reluctancy to take prescription medication, partnered with innovative offerings boost growth in herbal/traditional sleep aids across the forecast period
- A growing focus on alternative therapy across the forecast period could boost the reputation and retail sales of herbal/traditional products
- Table 88 Sales of Herbal/Traditional Products by Category: Value 2015-2020
- Table 89 Sales of Herbal/Traditional Products by Category: % Value Growth 2015-2020
- Table 90 NBO Company Shares of Herbal/Traditional Products: % Value 2016-2020
- Table 91 LBN Brand Shares of Herbal/Traditional Products: % Value 2017-2020
- Table 92 Forecast Sales of Herbal/Traditional Products by Category: Value 2020-2025
- Table 93 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2020-2025
2020 IMPACT
- Paediatric acetaminophen performs well, while negative press leads to a decline in sales for paediatric ibuprofen
- Although Rx medications remain an ongoing threat, due to the COVID-19 virus, paediatric cough, cold and allergy remedies record double-digit value growth
- Orkla Health AS retains its lead while Karo Pharma benefits from increased interest in paediatrics analgesics, boosting sales of Paracet
- Growth to be steady across the forecast period, albeit, lower than 2020, as demand for acetaminophen returns to normal
- Nappy (diaper) rash treatments and paediatric cough/cold remedies benefit from children in Norway suffering from a high level of eczema and coughs and colds
- Players compete through packaging and designs, while retailers make more space for paediatric consumer health products, boosting sales
- Table 94 Sales of Paediatric Consumer Health by Category: Value 2015-2020
- Table 95 Sales of Paediatric Consumer Health by Category: % Value Growth 2015-2020
- Table 96 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2015-2020
- Table 97 NBO Company Shares of Paediatric Consumer Health: % Value 2016-2020
- Table 98 LBN Brand Shares of Paediatric Consumer Health: % Value 2017-2020
- Table 99 Forecast Sales of Paediatric Consumer Health by Category: Value 2020-2025
- Table 100 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2020-2025
Note: Product cover images may vary from those shown
